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OBJECTIVE — The objective of this study was to determine if a community-based modified
Diabetes Prevention Program Group Lifestyle Balance (GLB) intervention, for individuals with
metabolic syndrome, was effective in decreasing risk for type 2 diabetes and cardiovascular
disease (CVD) in an urban medically underserved community, and subsequently to determine if
improvements in clinical outcomes could be sustained in the short term.
RESEARCH DESIGN AND METHODS — This nonrandomized prospective interven-
tion study used a one-group design to test the effectiveness of a community-based GLB inter-
vention. Residents from 11 targeted neighborhoods were screened for metabolic syndrome (n 
573) and took part in a 12-week GLB intervention (n  88) that addressed safe weight loss and
physical activity.
RESULTS — A marked decline in weight (46.4% lost 5% and 26.1% lost 7%) was ob-
served in individuals after completion of the intervention. Of these subjects, 87.5% (n  28) and
66.7% (n  12) sustained the 5% and 7% reduction, respectively, at the 6-month reassessment.
Over one-third of the population (43.5%, n  30) experienced improvements in one or more
component of metabolic syndrome, and 73.3% (n  22) sustained this improvement at the
6-month reassessment. Additional improvements occurred in waist circumference (P  0.009)
and blood pressure levels (P  0.04) after adjustment for age, sex, race, mean number of GLB
classes attended, and time.
CONCLUSIONS — Adults in an urban medically underserved community can decrease
their risk for type 2 diabetes and CVD through participation in a GLB intervention, and short-
term sustainability is feasible. Future research will include long-term follow-up of these subjects.
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T ype 2 diabetes is a prevalent costlycondition that disproportionatelyaffects disadvantaged populations
(1). Approximately 54 million American
adults age 20 years had pre-diabetes in
2002, placing them at substantially in-
creased risk for developing type 2 diabe-
tes (2). Because the prevalence of type 2
diabetes in the U.S. is expected to more
than double by the year 2050, reducing
type 2 diabetes risk is a public health pri-
ority (3).
Obesity and sedentary lifestyle are
risk factors for type 2 diabetes, since they
interact multiplicatively in the develop-
ment of the disease. Substantial evidence
demonstrates that intensive lifestyle inter-
vention (ILI) can reduce the incidence of
type 2 diabetes in individuals at risk (4–
6). The Diabetes Prevention Program
(DPP) demonstrated a 58% reduction in
incidence of type 2 diabetes in subjects
who were randomized to the ILI group of
the program (5). The ILI consisted of a
structured diet and increased physical ac-
tivity, without medication intervention.
Significant reduction of incidence of type
2 diabetes occurred regardless of ethnic-
ity, age, or sex. Moreover, the ILI was ef-
fective in reducing risk for cardiovascular
disease (CVD) and components of the
metabolic syndrome, while remaining
cost-effective (7,8)
Although the DPP’s intensive meth-
odology was necessary to study the effi-
cacy of lifestyle change in preventing type
2 diabetes, it is not easily replicated in
community settings (9). Indeed, transla-
tion of this evidence into community set-
tings remains limited. Therefore, our
objective was to determine if a communi-
ty-based modified DPP Group Lifestyle
Balance (GLB) intervention, for individu-
als with metabolic syndrome, is effective
in decreasing risk for type 2 diabetes and
CVD in an urban medically underserved
community, and subsequently to deter-
mine if improvements in clinical out-
comes can be sustained in the short term.
RESEARCH DESIGN AND
METHODS — This study was a non-
randomized prospective intervention
study that used a one-group design to test
the effectiveness of a community-based
GLB intervention. Recruitment for the
study began in April 2005 in 11 urban
medically underserved neighborhoods
near Pittsburgh, Pennsylvania. This is the
primary service area of the community
hospital and served as the study’s base
location.
The target community was a former
hub of the steel industry that experienced
industrial downsizing in the 1980s. This
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led to increased rates of unemployment
and out-migration of the young and more
affluent, resulting in a predominately
older socioeconomically depressed popu-
lation with a high prevalence of chronic
disease. Caucasians and African Ameri-
cans are the predominate racial groups,
with African Americans making up 36%
of the community population compared
with 13.1% in Allegheny county and
10.6% in Pennsylvania (U.S. Census Bu-
reau, 2000 Census). The study was car-
ried out in two phases: phase I,
community-based screening to determine
GLB intervention eligibility, and phase II,
provision of the GLB intervention with 3-
and 6-month reassessments. Follow-up
remains ongoing. The study design is out-
lined in Fig. 1.
Phase I: community-based screening
Adults aged 18 years and older from the
11 targeted neighborhoods were eligible
to be screened for metabolic syndrome.
Recruitment involved posting flyers in
churches, physician offices, worksites,
and store fronts, as well as placing infor-
mation in the local newspaper and on the
local cable broadcast channel. People
were not eligible for screening if they re-
ported a diagnosis of diabetes or a current
prescription for glucose-lowering medi-
cation, were pregnant, could not walk a
quarter of a mile without stopping, had
had bariatric surgery, were currently us-
ing weight-loss medications, or could not
provide informed consent.
A total of 573 people attended one of
35 screenings during 2005–2006 to de-
termine intervention eligibility. Screen-
ings were offered at no cost in churches,
worksites, and other community loca-
tions in the 11 neighborhoods. Eligible
subjects had to have a BMI 25 kg/m2,
physician consent to exercise, and at least
three of the five components of metabolic
syndrome as defined by the National
Cholesterol Education Program’s Adult
Treatment Panel III (10). Study staff (a
registered dietitian, an exercise specialist,
and two lay health coaches [LHC]) facili-
tated all screenings. The local hospital
provided the phlebotomist and lab ser-
vices. All staff were certified in standard-
ized outcomes measurement consistent
with the DPP.
After providing informed consent and
completing a demographic questionnaire,
participants had height, weight, waist cir-
cumference, and blood pressure mea-
sured according to standard protocol.
Blood samples were collected after an 8-h
fast to determine glucose, triglycerides,
and HDL cholesterol levels. Triglycerides
and HDL cholesterol were measured by
enzymatic assays using the Dade Behring
RXL. Blood glucose was measured by the
hexokinase method using the Dade
Behring RXL. Screening results were
mailed to participants and their physi-
cians. Eligible subjects (n  185) were
invited to participate in the GLB interven-
tion (Fig. 1).
Phase II: modified GLB intervention
The original DPP ILI was developed at the
University of Pittsburgh by the DPP Life-
style Resource Core and has been de-
scribed in detail elsewhere (9). Members
of the DPP lifestyle team adapted the in-
dividual ILI to a group-based program,
reconfiguring the 16 sessions into 12 ses-
sions while maintaining key concepts. As
in the original DPP ILI, the goals of the
GLB intervention were to achieve and main-
tain a 7% weight loss and to progressively
increase physical activity to 150 min/
week of moderately intense physical
activity. The modifications to the inter-
vention were as follows: DPP inter-
vention: 16 sessions over 24 weeks,
individual counseling, food pyramid, fat
intake, and brief introduction to pedom-
eter; modified GLB: 12 weekly sessions
over 12–14 weeks, group classes, healthy
food choices, emphasis on fat intake and
calories, and more emphasis on pedometer.
Two trained “preventionists” (one di-
etitian and one exercise specialist) were
responsible for delivery of the GLB inter-
vention, which took place in the 11 tar-
Figure 1—Study design of a nonrandomized prospective GLB intervention study. *Per informal
conversations between subjects and LHC. †One cohort had not reached 6-month mark at time of
data analysis.
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geted neighborhoods and was held
weekly for 12 weeks and lasted 90 min.
Group size ranged from 5 to 13 partici-
pants. The preventionists attended a
2-day training workshop, delivered by
members of the original DPP lifestyle
team that addressed how to properly de-
liver each of the 12 modified sessions.
This workshop was conducted by the
University of Pittsburgh’s Diabetes Pre-
vention Support Center. As part of the
LHC training, the LHCs acted as partici-
pants in a GLB intervention to gain per-
spective on participant needs and
concerns. LHCs communicated with par-
ticipants and physician offices and iden-
tified barriers and solutions to promote
program engagement and retention. They
also aided in study logistics and shared
relevant experiences to initiate class dis-
cussion. LHC performance was observed
daily by professional staff.
Of the 185 eligible subjects, 88 en-
rolled in the intervention (Fig. 1). Each
subject received a copy of the GLB hand-
outs, a fat and calorie counter, self-
monitoring books for keeping track of
food and physical activity, a pedometer,
measuring cups and spoons, a chart for
recording weekly weights, and a free
6-month membership to the local YMCA.
All subjects were asked to self-monitor
food intake and physical activity through-
out the 12-week intervention and were
given feedback concerning progress.
GLB intervention measures. Anthro-
pometric (height, weight, blood pressure,
and waist circumference) and laboratory
data (glucose, triglycerides, and HDL
cholesterol) were subsequently collected
at the 3- and 6-month reassessments. Par-
ticipants and their physicians received
copies of the results. A total of 69 partic-
ipants provided 3-month data, yielding a
response rate of 78.4%. There were 50
participants who provided 6-month data,
with a response rate of 56.8%. Individuals
who did not complete the intervention
were significantly older, and a greater
proportion was non-Caucasian in com-
parison to those who completed the inter-
vention. There was no difference in
education level between groups.
Study outcomes
There were two primary outcomes of the
intervention: 1) 5% or 7% weight loss
from baseline to 3- and 6-month fol-
low-up and 2) improvement of at least
one metabolic syndrome component
from baseline to 3- and 6-month follow-
up. Secondary outcomes were improve-
ments in triglycerides, abdominal obesity,
hypertension status, HDL cholesterol,
and glucose levels. The University of
Pittsburgh Institutional Review Board ap-
proved the study protocols, and all par-
ticipants provided informed consent.
Analyses
Analyses and results presented in this re-
port will focus on short-term (3- and
6-month) outcomes of the GLB interven-
tion. A future report will examine long-
term (18 months) outcomes. All
analyses were conducted at the individual
level. Analyses were not “intent to treat,”
since the study design was a nonrandom-
ized intervention study. However, a last-
response-carried-forward imputation was
conducted to estimate the impact of attri-
tion on the results. Six-month follow-up
data were imputed for 19 individuals.
Measures of central tendency (e.g., pro-
portions, means, SDs, medians, etc.) were
used for all descriptive analyses. Student’s
t tests and Pearson 2 tests were used to
determine differences between the GLB
intervention population (n  88) and the
screening population (n  573). McNe-
mar’s test for discrete data were used to
determine differences between baseline
and 3- and 6-month reassessment in the
intervention population. A 2 test for
trend was used to determine unadjusted
trends over time. To adjust for the effect of
possible confounders and to examine the
data in a continuous manner to allow for
improvements to be observed even if met-
abolic syndrome criteria were not met,
mixed modeling, using individual growth
curve analysis, was used. Age centered at
a mean age of 54.0 years, sex, race, mean
number of intervention classes attended,
and time were forced into all models. P
values 0.1 were used to determine
trends in the data. P 0.05 were consid-
ered statistically significant. All analyses
were conducted using SAS version 8.2
(SAS Institute, Cary, NC).
RESULTS — Basel ine populat ion
characteristics of the 88 subjects who
took part in the GLB intervention are pre-
sented in Table 1. The majority of subjects
were female (84.1%), non-Hispanic white
(72.7%), and an average of 54 years old.
Approximately three-fourths of the pop-
ulation had at least a high school educa-
tion (77.4%) and a family history of
diabetes (71.1%). Nearly 60% of the study
households had an annual income below
200% of the poverty level ($41,300 for a
family of four). Sixty-nine percent of sub-
jects attended at least 75% of GLB classes.
When comparing the GLB intervention
population to the overall screening popula-
tion to determine generalizability, no statis-
tically significant differences were apparent
(age: GLB [54.0  10.5 years] vs. screening
[53.7  15.6], P  0.86; sex: GLB [% fe-
male: 84.1] vs. screening [75.2], P  0.07;
race: GLB [% non-Hispanic white: 72.7] vs.
screening [72.3], P  0.93).
Table 1 also depicts the proportion of
GLB subjects with each component of
metabolic syndrome at baseline. Abdom-
inal obesity was the most prevalent
(93.2%), followed by abnormal HDL cho-
lesterol (84.1%), hypertension (68.2%),




Age (years) 54.0  10.5
Race (% non-Hispanic white) 72.7 (64)
Female (%) 84.1 (74)
At least a high school diploma (% yes) 77.4 (68)
Poverty 200% ($41,300/year for household of four) 59.7 (37)
Family history of diabetes (% yes) 71.1 (63)
Class attendance (attended 75% of classes) 69.3 (61)
Weight (lb) 216.8  40.7
Components of the metabolic syndrome*
Abdominal obesity (102 cm in males, 88 cm in females) 93.2 (82)
Abnormal HDL cholesterol (40 mg/dl in males, 50 mg/dl in females) 84.1 (74)
Hypertension (blood pressure 130/85 mmHg) 68.2 (60)
Triglycerides 150 mg/dl (% yes) 47.7 (42)
Glucose 100 mg/dl (% yes) 40.9 (36)
*National Cholesterol Education Program’s Adult Treatment Panel III. n  88.
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high triglyceride levels (47.7%), and in-
creased glucose (40.9%).
Analysis of a 5% and 7% weight re-
duction was conducted on the 69 subjects
who provided data at 3 months. In sub-
jects who provided data at this time,
46.4% (32) lost at least 5% of their body
weight, whereas 26.1% (18) lost at least
7%. A total of 87.5% (28) and 66.7% (12)
of these subjects sustained the 5% and 7%
reduction, respectively, at the 6-month
reassessment. When improvement in
metabolic syndrome components was ex-
amined, similar patterns were observed.
Over one-third of the population (43.5%,
n  30) experienced improvements in
one or more component of metabolic syn-
drome at 3 months, and 73.3% (22) of
these subjects sustained this improve-
ment at 6 months.
When change in the proportion of
subjects who met individual metabolic
syndrome criteria was examined over
time, significant trends were observed
(Table 2). Most notably, the proportion of
subjects with abdominal obesity de-
creased significantly over time (baseline:
90% [45]; 3 months: 82% [41]; 6 months:
68% [34]; P for trend  0.006). This sig-
nificant reduction remained despite ad-
justment for age, sex, race, and the
number of intervention classes attended
(adjusted P  0.009). A similar pattern
was observed for subjects with hyperten-
sion (baseline: 68% [34]; 3 months: 58%
[29]; 6 months: 48% [24]; P for trend 
0.04, adjusted P  0.04). The proportion
of subjects with triglyceride levels 150
mg/dl (baseline: 58% [29]; 3 months:
32.7% [16]; 6 months: 36.7% [18]; P for
trend  0.006, adjusted P  0.6) and
abnormal HDL cholesterol levels also im-
proved over time (baseline: 86% [43]; 3
months: 87.8% [43]; 6 months: 65.3%
[32], P for trend  0.001, adjusted P 
0.63); however, after adjustment for age,
sex, race, and class attendance, these sig-
nificant associations were attenuated. In
contrast to the other components of met-
abolic syndrome, the proportion of sub-
jects with glucose 100 mg/dl increased
over time (baseline: 42% [21]; 3 months:
51% [25]; 6 months: 61.2% [30], P for
trend  0.06, adjusted P  0.01) (Table
2). Imputation analyses revealed the same
pattern of significant results.
CONCLUSIONS — There are two
principle findings from this nonrandom-
ized prospective intervention study.
Nearly half of subjects (n  32) who par-
ticipated in a 12-week GLB intervention
lost at least 5% of their body weight, and
1/3 (n  18) lost at least 7%. A total of
87.5% (n  28) and 66.7% (n  12) of
subjects sustained the 5% and 7% reduc-
tions, respectively, at the 6-month reas-
sessment. Similar patterns were observed
for improvements in metabolic syndrome
parameters with over one-third (n  30)
of the population experiencing improve-
ments in one or more component of met-
abolic syndrome, and 73.3% (n  22) of
subjects sustained this improvement at
the 6-month reassessment. Additionally,
significant improvements occurred in
waist circumference, blood pressure, trig-
lycerides, and HDL cholesterol levels.
To our knowledge, this is one of few
reports to demonstrate the feasibility and
effectiveness of translating the national
DPP into an urban medically underserved
community. Moreover, it is one of very
few that demonstrated sustained weight
loss and metabolic syndrome risk reduc-
tion in a community setting. Numerous
studies reported initial weight loss and re-
duction in metabolic syndrome risk pa-
rameters immediately after a lifestyle
intervention; however, they did not re-
port the maintenance of health outcomes
(11–13).
Translating the national DPP into the
targeted community required an adapta-
tion of the original DPP methodologies to
better suit diverse populations, resources,
and selected nonclinical screening sites.
Our study used the presence of over-
weight (BMI 25 kg/m2) and metabolic
syndrome as a practical relatively low-
cost proxy for determining type 2 diabe-
tes and CVD risk and intervention
eligibility in place of the oral glucose tol-
erance test (14–17). Fasting blood work
was required, along with anthropometric
measurements. Indeed, many programs
avoid fasting blood work when recruiting
for diabetes prevention programs and in-
stead use anthropometric measurements,
diabetes risk questionnaires, and knowl-
edge and behavior surveys to determine
diabetes and/or CVD risk (18–20). Mea-
suring BMI and laboratory data enabled
us to assess whether our intervention was
indeed effective in reducing risk for type 2
diabetes and CVD among participants.
Another example of adapting the na-
tional DPP to the community setting is the
use of LHCs in our study. The LHCs were
members of the study community and
fostered a comfortable and familiar atmo-
sphere for participants. LHCs scheduled
follow-up visits, encouraged participa-
tion, and provided any missed informa-
tion. This may have contributed to high
class attendance, since 77% of subjects
completed the program. These comple-
tion and attendance rates compare posi-
tively to other community-based programs
(11,20,21).
Sustainable weight loss is often the
goal for interventions aimed at preventing
or delaying type 2 diabetes and CVD
(5,7,18,21). The weight loss goal in the
national DPP was 7%; however, other
studies have found a 5% loss to be clini-
Table 2—Change in the proportion of subjects meeting the criteria for components of the metabolic syndrome over time after the GLB










Abdominal obesity (102 cm in males, 88 cm in
females)
90.0 (45) 82.0 (41) 68.0 (34) 0.006 0.009
Abnormal HDL cholesterol (40 mg/dl in males,
50 mg/dl in females)
86.0 (43) 87.8 (43) 65.3 (32) 0.001 0.63
Hypertension (blood pressure 130/85 mmHg) 68.0 (34) 58.0 (29) 48.0 (24) 0.04 0.04
Triglycerides 150 mg/dl (% yes) 58.0 (29) 32.7 (16) 36.7 (18) 0.006 0.6
Glucose 100 mg/dl (% yes) 42.0 (21) 51.0 (25) 61.2 (30) 0.06 0.01
*Data presented are % (n) unless otherwise indicated. n  50. All analyses are adjusted for age, sex, race, mean number of GLB classes attended, and time.
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cally significant (11,20). Of those who
lost at least 5% of their body weight at 3
months, a greater proportion was able to
sustain this improvement than those who
lost at least 7% of their body weight.
Lack of accuracy in self-reporting of
food consumption and physical activity is
commonly documented in weight loss
studies (22). This study goes without ex-
ception. There was an overall resistance
toward self-reporting both food con-
sumption and activity levels. Calories and
fat grams were often inaccurately docu-
mented, and portion sizes were usually
not recorded. A similar pattern occurred
when reporting minutes of activity. Al-
though pedometers were introduced to
help track daily activity, there was reluc-
tance in using them. Common barriers in-
cluded inaccuracy or inconvenience.
Given these issues, these data were not
considered. Nonetheless, participants
verbally indicated minimal success
achieving the physical activity goal of 150
min per week. Perhaps a method to obtain
activity measures could include tracking
the frequency of gym visits. Although it
should be noted, despite the free YMCA
membership, only 55 of the 88 partici-
pants obtained their membership. Rea-
sons for not using the YMCA included
perceived lack of time, distance, and ap-
prehension toward a facility atmosphere.
Although food intake and physical ac-
tivity data were not captured, subjects ex-
perienced improvements in weight and
most parameters of metabolic syndrome
after the intervention. Unexpectedly, the
percentage of subjects with a glucose level
100 mg/dl rose at both the 3- and
6-month reassessments. Physical inactiv-
ity may explain this finding, since activity
aids in the regulation of blood glucose in
people without diabetes regardless of
body mass (23). Improvement in blood
glucose may be seen with further weight
loss and increases in physical activity.
In conducting translational research,
circumstances and environments are not
“controllable,” like efficacy-based research;
therefore, limitations exist. For example, all
subjects were volunteers able to attend
morning screenings. This inherently intro-
duced volunteer bias, since only those avail-
able in the morning could participate, and
may have contributed to the small sample
size of the cohort. Additionally, as with
most community studies, males were un-
derrepresented with 26% participation. Ef-
forts to recruit more men may include the
use of male LHCs and targeting traditional
male professions. Modified strategies to
avoid fasting blood work may enhance re-
cruitment of both male and females in need
of more flexible screening schedules.
Our study was underpowered to de-
tect significant differences in the primary
and secondary outcomes due to the small
sample size. Initial sample size calcula-
tions estimated that 190 subjects would
provide sufficient power to demonstrate
valid changes in the proportion of sub-
jects who decrease at least one parameter
of metabolic syndrome. Therefore, it is
possible these findings are subject to type
II error where we failed to detect a differ-
ence when one truly existed. Thus, if
there were improvements, we were un-
able to detect them. However, those find-
ings that showed statistically significant
differences represent true differences. As
attrition may be perceived as a major lim-
itation in our data, we performed last-
response-carried-forward imputations for
the 19 individuals who did provide
6-month follow-up data. The results
remained unchanged with the same sig-
nificant pattern as was seen in the non-
imputed analyses. While imputation
analyses allow adjustment for attrition, it
must be noted that they provide an over-
estimation of the intervention effect.
These preliminary results suggest that
adults in an urban medically underserved
community can decrease their risk for
type 2 diabetes and CVD through partic-
ipation in a GLB intervention, and short-
term sustainability is feasible. As a result,
a local insurer became interested in this
initiative. Discussions are underway for
making primary prevention a billable and
reimbursable service in the Pittsburgh
area. Future analysis will include long-
term follow-up of these subjects.
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